Raymond James & Associates’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.5M | Sell |
31,949
-6,484
| -17% | -$305K | ﹤0.01% | 2416 |
|
|
2024
Q2 | $2.08M | Buy |
38,433
+3,479
| +10% | +$188K | ﹤0.01% | 2147 |
|
|
2024
Q1 | $2.38M | Buy |
34,954
+3,115
| +10% | +$212K | ﹤0.01% | 2049 |
|
|
2023
Q4 | $1.99M | Buy |
31,839
+3,231
| +11% | +$202K | ﹤0.01% | 2091 |
|
|
2023
Q3 | $1.3M | Sell |
28,608
-159
| -0.6% | -$7.22K | ﹤0.01% | 2279 |
|
|
2023
Q2 | $1.61M | Sell |
28,767
-28,365
| -50% | -$1.59M | ﹤0.01% | 2177 |
|
|
2023
Q1 | $2.58M | Buy |
57,132
+13,729
| +32% | +$621K | ﹤0.01% | 1874 |
|
|
2022
Q4 | $1.76M | Buy |
43,403
+6,176
| +17% | +$251K | ﹤0.01% | 2071 |
|
|
2022
Q3 | $2.43M | Buy |
37,227
+3,972
| +12% | +$260K | ﹤0.01% | 1847 |
|
|
2022
Q2 | $2.02M | Sell |
33,255
-18,335
| -36% | -$1.11M | ﹤0.01% | 1970 |
|
|
2022
Q1 | $3.24M | Sell |
51,590
-8,467
| -14% | -$531K | ﹤0.01% | 1809 |
|
|
2021
Q4 | $4.55M | Sell |
60,057
-27,729
| -32% | -$2.1M | ﹤0.01% | 1617 |
|
|
2021
Q3 | $9.83M | Buy |
87,786
+8,479
| +11% | +$949K | 0.01% | 1063 |
|
|
2021
Q2 | $12.8M | Buy |
79,307
+16,859
| +27% | +$2.73M | 0.01% | 936 |
|
|
2021
Q1 | $7.61M | Buy |
62,448
+862
| +1% | +$105K | 0.01% | 1184 |
|
|
2020
Q4 | $9.43M | Buy |
61,586
+2,492
| +4% | +$382K | 0.01% | 990 |
|
|
2020
Q3 | $4.94M | Buy |
59,094
+3,828
| +7% | +$320K | 0.01% | 1235 |
|
|
2020
Q2 | $4.06M | Sell |
55,266
-684
| -1% | -$50.3K | 0.01% | 1315 |
|
|
2020
Q1 | $2.37M | Buy |
55,950
+5,322
| +11% | +$226K | ﹤0.01% | 1471 |
|
|
2019
Q4 | $3.08M | Sell |
50,628
-4,646
| -8% | -$283K | ﹤0.01% | 1560 |
|
|
2019
Q3 | $2.27M | Buy |
55,274
+2,244
| +4% | +$92K | ﹤0.01% | 1702 |
|
|
2019
Q2 | $2.5M | Buy |
53,030
+1,433
| +3% | +$67.5K | ﹤0.01% | 1662 |
|
|
2019
Q1 | $1.84M | Buy |
51,597
+3,040
| +6% | +$109K | ﹤0.01% | 1816 |
|
|
2018
Q4 | $1.39M | Buy |
48,557
+5,227
| +12% | +$149K | ﹤0.01% | 1874 |
|
|
2018
Q3 | $1.92M | Sell |
43,330
-38,476
| -47% | -$1.71M | ﹤0.01% | 1832 |
|
|
2018
Q2 | $4.81M | Sell |
81,806
-525
| -0.6% | -$30.9K | 0.01% | 1207 |
|
|
2018
Q1 | $3.76M | Sell |
82,331
-507
| -0.6% | -$23.2K | 0.01% | 1311 |
|
|
2017
Q4 | $1.95M | Buy |
82,838
+34,178
| +70% | +$802K | ﹤0.01% | 1710 |
|
|
2017
Q3 | $870K | Buy |
48,660
+28,651
| +143% | +$512K | ﹤0.01% | 2175 |
|
|
2017
Q2 | $321K | Buy |
+20,009
| New | +$321K | ﹤0.01% | 2664 |
|